Persistence of botulinum neurotoxin action in cultured spinal cord cells

FEBS Letters

Volumn 456, Issue 1, 1999, Pages 137-142

  Keller, James E ^a   Neale, Elaine A ^b   Oyler, George ^c   Adler, Michael ^a  

^a Neurotoxicology Branch   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Botulinum neurotoxin; Spinal cord culture; Synaptosomal associated protein of 25 kDa (SNAP 25)

Indexed keywords

BOTULINUM TOXIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; IMMUNOBLOTTING; IN VITRO STUDY; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; SPINAL CORD;

AMINO ACID SEQUENCE; ANIMALS; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; CELLS, CULTURED; FEMALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PEPTIDE HYDROLASES; SPINAL CORD; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 0032776446     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00948-5     Document Type: Article

References (29)

1. Habermann E., Dreyer F. Curr. Top. Microbiol. Immunol. 129:1986;93-179.
2. Simpson, L.L. (1989) in: Botulinum Neurotoxin and Tetanus Toxin (Simpson, L.L., Ed.), Academic Press, New York, pp. 153-178.
3. Niemann H., Blasi J., Jahn R. Trends Cell Biol. 4:1994;179-185.
4. Antharavally B., Tepp W., DasGupta B.R. J. Protein Chem. 17:1998;187-196.
5. Blasi J., Chapaman E., Link E., Binz T., Yamasaki S., De Camilli P., Sudhof T., Niemann T., Jahn R. Nature. 365:1993;160-163.
6. Montecucco C., Schiavo G. Mol. Microbiol. 13:1994;1-8.
7. Hayashi T., McMahon H., Yamasaki S., Binz T., Hata Y., Sudhof T., Niemann H. EMBO J. 13:1994;5051-5061.
8. Binz T., Blasi J., Yamasaki S., Baumeister A., Link E., Sudhof T.C., Jahn R., Niemann H. J. Biol. Chem. 269:1994;1617-1620.
9. Sellin L.C., Thesleff S., DasGupta B.R. Acta Physiol. Scand. 119:1983;127-133.
10. Sellin L.C., Kauffman J.A., DasGupta B.R. Med. Biol. 61:1983;120-125.
11. Scott A.B. J. Am. Ophthalmol. Soc. 79:1981;734-770.
12. Gutierrez L., Viniegra S., Rueda J.l., Ferrer-Montiel A., Canaves J., Montal M. J. Biol. Chem. 272:1997;2.
13. Ferrer-Montiel A.V., Gutiérrez L.M., Apland J.P., Canaves J.M., Gil A., Viniegra S., Biser J.A., Adler M., Montal M. FEBS Lett. 435:1998;84-88.
14. Adler, M., Keller, J.E., Sheridan, R.E. and Desphande, S.S. (1999) Toxicon, submitted.
15. Erdal E., Bartels F., Binscheck T., Erdmann G., Frevert J., Kistner A., Weller U., Weaver J., Bigalke H. Naunyn-Schmiedebergs Arch. Pharmacol. 351:1995;67-78.
16. Williamson L.C., Fitzgerald S.C., Neale E.A. J. Neurochem. 59:1992;2148-2157.
17. Ransom B.R., Neale E., Henkart M., Bullock R.N. J. Neurophysiol. 40:1977;1132-1150.
18. Fitzgerald, S.C. (1989) in: A Dissection and Tissue Culture Manual of the Nervous System (Shahar, A., deVellis, J., Vernadakis, A. and Haber, B., Eds.), Alan R. Liss, Inc., New York, pp. 219-222.
19. Laemmli U.K. Nature. 227:1970;680-685.
20. Schagger H., von Jagow G. Anal. Biochem. 166:1987;368-379.
21. Molgo J., Dasgupta B.R., Thesleff S. Acta Physiol. Scand. 137:1989;497-501.
22. Parpura V., Fang Y., Basarsky T., Jahn R., Haydon P.G. FEBS Lett. 377:1995;489-492.
23. Jeftinija S.D., Jeftinija K.V., Stefanovic G. Brain Res. 750:1997;41-47.
24. Blasi J., Chapman E., Link E., Binz T., Yamasaki S., De Camilli P., Sudhof T., Niemann T., Jahn R. Nature. 365:1993;160-163.
25. Schiavo G., Santucci A., DasGupta B.R., Mehta P.P., Jontes J., Benfenati F., Wilson M.C., Montecucco C. FEBS Lett. 335:1993;99-103.
26. Diaz J., Molgo J., Pecot-Dechavassine M. Neurosci. Lett. 96:1989;127-132.
27. Huang X., Wheeler M.B., Kang Y.H., Sheu L., Lukacs G.L., Trimble W.S., Gaisano H.Y. Mol. Endocrinol. 12:1998;1060-1070.
28. Loewy A., Liu W., Baitinger C., Willard M. J. Neurosci. 11:1991;3412-3421.
29. Eleopra R., Tugnoli V., Rosetto O., De Grandis D., Montecucco C. Neurosci. Lett. 256:1998;135-138.